Vascular endothelial growth factor and renal cell carcinoma
10.3760/cma.j.issn.1673-422X.2012.02.022
- VernacularTitle:血管内皮生长因子与肾细胞癌
- Author:
Shukui ZHOU
;
Shunping WANG
;
Yuemin WANG
- Publication Type:Journal Article
- Keywords:
Vascular endothelial growth factors;
Kidney neoplasms;
Therapeutic uses
- From:
Journal of International Oncology
2012;39(2):148-151
- CountryChina
- Language:Chinese
-
Abstract:
Vascular endothelial growth factor(VEGF) is high expressed in the organization of renal cell carcinoma and is mainly regulated by VHL gene and hypoxic of organization.Moreover,it can be used as a biomarker to judge renal cell carcinoma tumor progression and prognostic.In recent years,anti-VEGF targeted drugs are used for the treatment of renal cell carcinoma and receive meaningful clinical benefits.
